Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ickx, B. E.
Right arrow Articles by Van der Linden, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ickx, B. E.
Right arrow Articles by Van der Linden, P. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2003, Vol. 91, No. 2 196-202
© 2003 The Board of Management and Trustees of the British Journal of Anaesthesia

Clinical Investigations

Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution

B. E. Ickx1, F. Bepperling4, C. Melot2, C. Schulman3 and P. J. Van der Linden*,5

1 Department of Anaesthesiology, 2 Department of Intensive Care and 3 Department of Urology, Erasme University Hospital, 808 route de Lennik, B-1070 Brussels, Belgium. 4 Clinical Research, Fresenius Kabi, Bad Homburg, Germany. 5 Department of Cardiac Anaesthesia – BT4, CHU Charleroi, 92 Boulevard Paul Janson, B-6000 Charleroi, Belgium

Corresponding author. E-mail: philippe.vanderlinden@chu-charleroi.be
{dagger}Declaration of interest. Supported by a grant from Fresenius Kabi GmbH, Bad Homburg, Germany. Frank Bepperling is employed by Fresenius Kabi, 61346 Bad Homburg, Germany.

Background. The volume expansion effect of a recently introduced hydroxyethyl starch, HES 130/0.4, was compared with the commonly used HES 200/0.5 after rapid infusion of a single large dose (up to 2 litres) administered during acute normovolaemic haemodilution (ANH).

Methods. This prospective, randomized, double-blind study included 40 patients scheduled for major abdominal surgery with no contraindication to ANH. Patients were randomized to undergo ANH with either HES 130/0.4 (n=20) or HES 200/0.5 (n=20). Blood was collected to reach a target haemoglobin level of about 8.0 g dl–1 and simultaneously replaced by the same volume of colloid (HES 130: 1825 [SD 245] ml; HES 200: 1925 [183] ml). Heart rate, mean arterial pressure, cardiac filling pressure, and cardiac output were measured before induction of anaesthesia (baseline), 10 min after completion of ANH, before surgery, at the end of surgery and on the following morning (postoperative day 1; POD1). ANH blood was systematically retransfused during surgery or before POD1.

Results. Exchange of about 40% of blood volume resulted in similar haemodynamic changes in both groups. Filling pressures increased significantly, while cardiac index remained unchanged (HES 130: from 3.3 [0.4] to 3.2 [0.7] litre min–1 m–2; HES 200: from 3.0 [0.6] to 3.1 [0.7] litre min–1 m–2). Need for crystalloids and colloids was similar between the groups during surgery and on POD1. Total blood loss (HES 130: median 2165 ml, range 660–2970 ml; HES 200: median 2464 ml, range 640–19 380 ml) and amount of allogeneic red blood cells transfused (HES 130: median 0, range 0–4 units; HES 200: median 0, range 0–18 units) were comparable in the two groups.

Conclusions. This study demonstrates a good immediate and medium-term plasma volume substitution effect of HES 130 compared with HES 200. HES 130 could represent a suitable synthetic colloid for plasma volume substitution during extensive ANH.

Br J Anaesth 2003; 91: 196–202


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
C. Hartog, F. Brunkhorst, and K. Reinhart
Hydroxyethyl Starch 130/0.4 and Surgical Blood Loss
Anesth. Analg., February 1, 2009; 108(2): 672 - 672.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. A. Kozek-Langenecker, C. Jungheinrich, W. Sauermann, and P. van der Linden
Hydroxyethyl Starch 130/0.4 and Surgical Blood Loss
Anesth. Analg., February 1, 2009; 108(2): 672 - 673.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
V. Blasco, M. Leone, F. Antonini, A. Geissler, J. Albanese, and C. Martin
Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation
Br. J. Anaesth., April 1, 2008; 100(4): 504 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
D. A. Otsuki, D. T. Fantoni, C. B. Margarido, C. K. Marumo, T. Intelizano, C. A. Pasqualucci, and J. O. Costa Auler Jr
Hydroxyethyl starch is superior to lactated Ringer as a replacement fluid in a pig model of acute normovolaemic haemodilution
Br. J. Anaesth., January 1, 2007; 98(1): 29 - 37.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. A. Neff, L. Fischler, M. Mark, R. Stocker, and W. H. Reinhart
The Influence of Two Different Hydroxyethyl Starch Solutions (6% HES 130/0.4 and 200/0.5) on Blood Viscosity
Anesth. Analg., June 1, 2005; 100(6): 1773 - 1780.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.